Haleon UK Holding New Zealand Limited

In liquidation12342879 Private limited company
Incorporated
2 December 2019 (6 years)
Previously known as
GSK New Zealand Holding Company Limited (until 16 June 2023)
This list may be incomplete. See all names on Companies House
Industry
Activities of other holding companies n.e.c. (64209)
Directors
Owned by
Accounts type
Audit exemption subsidiary
Region
South East
Address
Building 5
First Floor
The Heights
Weybridge
KT13 0NY

Filing status

Accounts due
30 September 2026
Last accounts
31 December 2024
Conf. stmt due
30 August 2026
Last conf. stmt
16 August 2025

Officers

This list may be incomplete. See all officers on Companies House

Officer details are public data from the Companies House register.

Corporate Director · Appointed 6 April 2022
Also at Haleon UK Trading Limited, Haleon UK IP Limited, Haleon UK Research Limited · more companies
Corporate Director · Appointed 6 April 2022
Also at Haleon UK Trading Limited, Haleon UK IP Limited, Haleon UK Research Limited · more companies
Director · Appointed 4 March 2022
Also at Haleon UK Holding Sri Lanka Limited · more companies
Australian,British
Born November 1986
Officer history (5 former)
20 September 2024
Resigned Whittle, Thomas Ian as Director
6 April 2022
Resigned Edinburgh Pharmaceutical Industries Limited as Corporate Director
6 April 2022
Appointed Haleon UK Corporate Secretary Limited as Corporate Director
6 April 2022
Appointed Haleon UK Corporate Director Limited as Corporate Director
6 April 2022
Resigned Glaxo Group Limited as Corporate Director
4 March 2022
Appointed Di Pietro, Lee as Director
4 March 2022
Resigned Cottam, David John as Director
31 July 2020
Appointed Whittle, Thomas Ian as Director
31 July 2020
Resigned Aristidou, Antrinkos Andrew as Director
10 March 2020
Appointed Cottam, David John as Director
2 December 2019
Appointed Edinburgh Pharmaceutical Industries Limited as Corporate Director
2 December 2019
Appointed Aristidou, Antrinkos Andrew as Director
2 December 2019
Appointed Glaxo Group Limited as Corporate Director

Ownership 1 active

People and entities with significant control, from the Companies House PSC register

Corporate entity · Notified 28 May 2021
Owns 75–100% of shares
Holds 75–100% of voting rights
Right to appoint and remove directors
Private Company Limited By Shares
Reg. no. 13355627
Former controllers (2)
28 May 2021
Ceased Prism PCH Limited — Owns 75–100% of shares
28 May 2021
Ceased Glaxosmithkline Consumer Healthcare (Overseas) Limited — Owns 75–100% of shares

Group structure 8 shown

Ownership group derived from the Companies House PSC register

Consumer Healthcare Holdings Limited
Consumer Healthcare Intermediate Holdings Limited Owns 75–100% of shares
Haleon UK Holdings (No.7) Limited Owns 25–50% of shares
Haleon UK Corporate Secretary Limited Owns 75–100% of shares
Haleon UK Holdings (No.1) Limited Owns 75–100% of shares
Haleon UK Holding New Zealand Limited This company In liquidationOwns 75–100% of shares
Haleon UK Services Limited Owns 75–100% of shares
Haleon UK Research Limited Owns 75–100% of shares

Filings

Recent filings only. See the full history on Companies House

DateDescriptionMade Up ToPagesPDF
3 September 2026Return of final meeting in a members' voluntary winding up

Some other companies at this address

Consumer Healthcare Holdings Limited
Consumer Healthcare Intermediate Holdings Limited
Haleon Intermediate Holdings Limited
Haleon PLC
Haleon UK Capital PLC
Haleon UK Corporate Director Limited

Other companies in this industry

Derby
Oxford
Cheltenham
London
Spalding
Altrincham

Need accounts figures, ownership or websites for thousands of companies? Bulk data & API →

← Back to companies Official record on Companies House ↗

Already have an account?

Create your account

Save searches and get the weekly email of new matches.

First name is required.
Last name is required.
Enter an email address like name@example.com.
Must be at least 8 characters. Password must be at least 8 characters.

Already have an account?